Sun Pharmaceutical Industries Q3 Results
- BSE: 524715
- NSE: SUNPHARMA
- ISIN: INE044A01036
- Sector: Biotechnology & Drugs
BSE
1,952.75
3.75 (0.19%)
3.75 (0.19%)Volume5.80 L
Updated: Mon 10 Aug, 2026 | 15:51:07
NSE
1,944.40
-0.60 (-0.03%)
-0.60 (-0.03%)Volume1.73 M
Updated: Mon 10 Aug, 2026 | 15:51:41
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Sun Pharmaceutical Industries Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 11,947.78 | 10,106.43 | 7.53% | 9,720.38 | 14.55% |
| Depreciation/ Amortization | 732.33 | 625.91 | 0.39% | 622.14 | 16.14% |
| Operating Income | 3,572.76 | 3,184.96 | 6.11% | 2,660.32 | 10.08% |
| Net Income | 3,368.81 | 3,040.16 | 8.05% | 2,523.75 | 16.03% |
| Other Operating Expenses Total | 4,888.87 | 4,308.62 | 5.50% | 3,928.17 | 16.67% |
| Net Income Before Taxes | 4,227.16 | 3,597.88 | 1.43% | 3,000.35 | 21.60% |
| Total Revenue | 15,520.54 | 13,291.39 | 7.20% | 12,380.70 | 13.49% |
| Selling/ General/ Admin Expenses Total | 2,892.00 | 2,477.70 | 4.60% | 2,363.32 | 13.31% |
| Diluted Normalized EPS | 14.15 | 12.70 | 8.81% | 10.75 | 7.12% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.